- Home
- ILPT vs PYXS Comparison
ILPT vs PYXS Comparison
Compare ILPT & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILPT
- PYXS
- Stock Information
- Founded
- ILPT 2017
- PYXS 2018
- Country
- ILPT United States
- PYXS United States
- Employees
- ILPT N/A
- PYXS N/A
- Industry
- ILPT Real Estate Investment Trusts
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- ILPT Real Estate
- PYXS Health Care
- Exchange
- ILPT Nasdaq
- PYXS Nasdaq
- Market Cap
- ILPT 235.1M
- PYXS 210.4M
- IPO Year
- ILPT 2018
- PYXS 2021
- Fundamental
- Price
- ILPT $3.66
- PYXS $2.10
- Analyst Decision
- ILPT Buy
- PYXS Strong Buy
- Analyst Count
- ILPT 2
- PYXS 7
- Target Price
- ILPT $10.00
- PYXS $9.57
- AVG Volume (30 Days)
- ILPT 449.3K
- PYXS 1.5M
- Earning Date
- ILPT 10-29-2024
- PYXS 11-12-2024
- Dividend Yield
- ILPT 1.10%
- PYXS N/A
- EPS Growth
- ILPT N/A
- PYXS N/A
- EPS
- ILPT N/A
- PYXS N/A
- Revenue
- ILPT $440,696,000.00
- PYXS $16,146,000.00
- Revenue This Year
- ILPT N/A
- PYXS N/A
- Revenue Next Year
- ILPT $6.87
- PYXS N/A
- P/E Ratio
- ILPT N/A
- PYXS N/A
- Revenue Growth
- ILPT 1.36
- PYXS N/A
- 52 Week Low
- ILPT $2.93
- PYXS $1.35
- 52 Week High
- ILPT $5.45
- PYXS $6.85
- Technical
- Relative Strength Index (RSI)
- ILPT 40.10
- PYXS 24.53
- Support Level
- ILPT $3.54
- PYXS $3.88
- Resistance Level
- ILPT $3.84
- PYXS $4.31
- Average True Range (ATR)
- ILPT 0.16
- PYXS 0.36
- MACD
- ILPT 0.04
- PYXS -0.17
- Stochastic Oscillator
- ILPT 52.63
- PYXS 4.01
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.